Berberine

Berberine is a 6.5–7.0/10 fit for people considering blood sugar, metabolic health, cardiovascular, liver detox, with the strongest case in the populations already represented by the evidence rather than broad wellness use. Liu 2025 and Li 2024 give the report its main anchors, while the score stays Worth trying because benefits are context-dependent and the evidence still leaves responder, dose, and long-term questions open. Berberine makes the most sense when the target is concrete, such as a lab marker, symptom pattern, training limitation, or recovery bottleneck. It makes less sense as a background habit taken on faith. In practice, treat Berberine as a tracked experiment: define the outcome first, watch for tradeoffs, and let the response decide whether it earns a place.

✅ Best for: Adults with diagnosed type 2 diabetes, prediabetes, metabolic syndrome, elevated triglycerides, insulin-resistant PCOS, or NAFLD who want an adjunctive metabolic tool and can monitor labs. Berberine is especially relevant when metformin is not tolerated or accessible, but it should not replace clinician-directed diabetes care. It also fits selected short-course gut protocols, including H. pylori-adjacent regimens like Chen 2023, and possibly ulcerative-colitis adjunct care under GI supervision per Li 2024.

❌ Avoid if: You are pregnant, breastfeeding, trying to conceive without clinician guidance, caring for a neonate, jaundiced, or using transplant drugs, anticoagulants, CYP-sensitive psychiatric medications, macrolides, cyclosporine, tacrolimus, warfarin, DOACs, or complex polypharmacy without pharmacist clearance. Avoid berberine if you are metabolically healthy and chasing weight loss, generic longevity, or "nature's Ozempic" claims. EFSA's 2026 draft process also makes EU users a wait-and-see group until the final safety position is clear.